Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Judge 

Hologic Inc. diskutieren

Hologic Inc.

WKN: 879100 / Symbol: HOLX / Name: Hologic / Aktie / Ausrüstung & Versorgung / Large Cap /

64,00 €
-0,78 %

Einschätzung Buy
Rendite (%) -18,57 %
Kursziel 83,30
Veränderung
Endet am 30.07.25

Hologic, Inc. (NASDAQ: HOLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -23,49 %
Kursziel 87,87
Veränderung
Endet am 30.07.25

Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at JPMorgan Chase & Co. from $91.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -25,49 %
Kursziel 85,11
Veränderung
Endet am 30.07.25

Hologic, Inc. (NASDAQ: HOLX) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $92.00 price target on the stock.
Ratings data for HOLX provided by MarketBeat

Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for HOLX provided by MarketBeat

Hologic, Inc. (NASDAQ: HOLX) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -21,92 %
Kursziel 80,87
Veränderung
Endet am 17.09.25

Hologic, Inc. (NASDAQ: HOLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.
Ratings data for HOLX provided by MarketBeat

Hologic, Inc. (NASDAQ: HOLX) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -19,31 %
Kursziel 82,10
Veränderung
Endet am 04.10.25

Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Mizuho from $85.00 to $90.00. They now have an "outperform" rating on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -19,86 %
Kursziel 81,95
Veränderung
Endet am 08.10.25

Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Leerink Partners from $95.00 to $90.00. They now have an "outperform" rating on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -23,84 %
Kursziel 82,47
Veränderung
Endet am 15.10.25

Hologic, Inc. (NASDAQ: HOLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -12,93 %
Kursziel 86,08
Veränderung
Endet am 05.11.25

Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at JPMorgan Chase & Co. from $92.00 to $94.00. They now have an "overweight" rating on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -11,72 %
Kursziel 79,58
Veränderung
Endet am 05.11.25

Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Mizuho from $90.00 to $87.00. They now have an "outperform" rating on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -11,72 %
Kursziel 86,90
Veränderung
Endet am 05.11.25

Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Raymond James from $93.00 to $95.00. They now have an "outperform" rating on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -13,61 %
Kursziel 85,54
Veränderung
Endet am 10.12.25

Hologic, Inc. (NASDAQ: HOLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -7,25 %
Kursziel 86,51
Veränderung
Endet am 19.12.25

Hologic, Inc. (NASDAQ: HOLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -7,91 %
Kursziel 88,14
Veränderung
Endet am 13.01.26

Hologic, Inc. (NASDAQ: HOLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,00 %
Kursziel 80,95
Veränderung
Endet am 06.02.26

Hologic, Inc. (NASDAQ: HOLX) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $84.00 price target on the stock.
Ratings data for HOLX provided by MarketBeat

Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,59 %
Kursziel 86,56
Veränderung
Endet am 06.02.26

Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $90.00 price target on the stock, down previously from $95.00.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) 35,59 %
Kursziel 62,86
Veränderung
Endet am 02.05.26

Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $71.00 price target on the stock, down previously from $90.00.
Ratings data for HOLX provided by MarketBeat